Compare GL & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GL | RVTY |
|---|---|---|
| Founded | 1900 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 9.9B |
| IPO Year | N/A | N/A |
| Metric | GL | RVTY |
|---|---|---|
| Price | $131.15 | $100.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $151.50 | $112.92 |
| AVG Volume (30 Days) | 476.4K | ★ 1.7M |
| Earning Date | 10-22-2025 | 10-27-2025 |
| Dividend Yield | ★ 0.82% | 0.28% |
| EPS Growth | ★ 16.72 | N/A |
| EPS | ★ 13.77 | 1.99 |
| Revenue | ★ $5,940,974,000.00 | $2,813,367,000.00 |
| Revenue This Year | $7.51 | $5.33 |
| Revenue Next Year | $5.15 | $3.07 |
| P/E Ratio | ★ $9.54 | $51.70 |
| Revenue Growth | ★ 3.73 | 3.37 |
| 52 Week Low | $100.62 | $81.36 |
| 52 Week High | $147.83 | $128.29 |
| Indicator | GL | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 57.32 |
| Support Level | $129.21 | $99.35 |
| Resistance Level | $132.02 | $104.84 |
| Average True Range (ATR) | 2.33 | 3.06 |
| MACD | -0.05 | 0.33 |
| Stochastic Oscillator | 26.80 | 66.03 |
Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.